IAMH
PRME icon

IvyRock Asset Management (HK)’s Prime Medicine PRME Stock Holding History

IvyRock Asset Management (HK)’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Hold
41,800
– – 0.09% 24
2026
Q1 		$145K Hold
41,800
– – 0.08% 24
2025
Q4 		$145K Hold
41,800
– – 0.08% 22
2025
Q3 		$232K Buy
+41,800
New +$170K 0.1% 17

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

IvyRock Asset Management (HK)'s PRME Position: Q2 2026 in Review

IvyRock Asset Management (HK) held its Prime Medicine (PRME) position steady in Q2 2026 at 41,800 shares worth $154K. The position accounts for 0.09% of the portfolio, ranked #24.

IvyRock Asset Management (HK) first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $232K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • IvyRock Asset Management (HK) held 41,800 shares of Prime Medicine worth $154K as of Q2 2026.
  • IvyRock Asset Management (HK) left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up 0.09% of IvyRock Asset Management (HK)'s portfolio in Q2 2026, its #24 holding.
  • IvyRock Asset Management (HK) first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • IvyRock Asset Management (HK)'s Prime Medicine position peaked at $232K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on IvyRock Asset Management (HK)'s 13F filing for Q2 2026, filed 4 Aug 2026.